Advertisement

Verquvo – Heart Failure – Display Banners HCP Wallboard Extension_Early Adopter – 26101

Dapagliflozin Cuts CV Risk in HF With Preserved LVEF

For patients with HF with mildly reduced or preserved ejection fraction, the sodium glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the combined risk for worsening HF or cardiovascular death, according to a study...

Read More

Acetazolamide Helps Treat Volume Overload in HF

For patients with acute decompensated HF, the addition of acetazolamide to loop diuretic therapy yields an increased incidence of successful decongestion, according to a study published in the New England Journal of Medicine....

Read More

For latest news and updates
Email-id is invalid